A detailed history of Canal Insurance CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Canal Insurance CO holds 120,000 shares of BMY stock, worth $4.98 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares
120,000
Previous 120,000 -0.0%
Holding current value
$4.98 Million
Previous $6.16 Million 5.7%
% of portfolio
1.67%
Previous 1.7%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $3.45 Million - $3.8 Million
-47,500 Reduced 28.36%
120,000 $9.24 Million
Q1 2022

Apr 22, 2022

SELL
$61.48 - $73.72 $153,700 - $184,300
-2,500 Reduced 1.47%
167,500 $12.2 Million
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $2.68 Million - $3.13 Million
50,000 Added 41.67%
170,000 $10.6 Million
Q4 2019

Feb 04, 2020

SELL
$49.21 - $64.19 $2.46 Million - $3.21 Million
-50,000 Reduced 29.41%
120,000 $7.7 Million
Q3 2019

Oct 24, 2019

SELL
$42.77 - $50.71 $2.14 Million - $2.54 Million
-50,000 Reduced 22.73%
170,000 $8.62 Million
Q1 2019

May 07, 2019

BUY
$45.12 - $53.8 $1.58 Million - $1.88 Million
35,000 Added 18.92%
220,000 $10.5 Million
Q4 2018

Feb 05, 2019

BUY
$48.76 - $63.23 $487,600 - $632,300
10,000 Added 5.71%
185,000 $9.62 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $3.04 Million - $3.42 Million
-55,000 Reduced 23.91%
175,000 $10.9 Million
Q2 2018

Aug 10, 2018

BUY
$50.53 - $62.98 $1.77 Million - $2.2 Million
35,000 Added 17.95%
230,000 $12.7 Million
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $1.2 Million - $1.38 Million
20,000 Added 11.43%
195,000 $0
Q4 2017

Jan 31, 2018

SELL
$59.94 - $65.35 $991,947 - $1.08 Million
-16,549 Reduced 8.64%
175,000 $10.7 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $10.6 Million - $12.2 Million
191,549
191,549 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Canal Insurance CO Portfolio

Follow Canal Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canal Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Canal Insurance CO with notifications on news.